摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-甲氧基-3-吲唑羧酸 | 90417-53-1

中文名称
5-甲氧基-3-吲唑羧酸
中文别名
5-甲氧基-1H-吲唑-3-羧酸;5-甲氧基-1H-茚唑-3-羧酸
英文名称
5-methoxy-1H-indazole-3-carboxylic acid
英文别名
5-methoxy-indazol-3-carboxylic acid;5-methoxy-1(2)H-indazole-3-carboxylic acid;5-methoxy-indazole-3-carboxylic acid;5-methoxyindazole-3-carboxylic acid;5-methoxy-1H-indazole-3-acid;5-Methoxy-indazol-3-carbonsaeure
5-甲氧基-3-吲唑羧酸化学式
CAS
90417-53-1
化学式
C9H8N2O3
mdl
MFCD03840712
分子量
192.174
InChiKey
RSERHJPLECECPR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    75.2
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933990090
  • 危险性防范说明:
    P305+P351+P338
  • 危险性描述:
    H302,H319

SDS

SDS:20fb3987a2d26110b40059fdc2b0dc1c
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 5-Methoxy-1h-indazole-3-carboxylic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 5-Methoxy-1h-indazole-3-carboxylic acid
CAS number: 90417-53-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H8N2O3
Molecular weight: 192.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    5-甲氧基-3-吲唑羧酸 在 lithium aluminium tetrahydride 作用下, 以 四氢呋喃 为溶剂, 反应 3.0h, 以68%的产率得到5-甲氧基-1H-吲唑-3-甲醇
    参考文献:
    名称:
    The Serotonin 5-HT4 Receptor. 2. Structure-Activity Studies of the Indole Carbazimidamide Class of Agonists
    摘要:
    A number of substituted indole carbazimidamides were prepared and evaluated as 5-HT4 receptor agonists by using the isolated field-stimulated guinea pig ileum preparation. Their selectivity for the 5-HT4 receptor was established by examining their affinity for other 5-HT receptors using radioligand-binding techniques. Several selective and highly potent full as well as partial agonists emerged from this study. For example, 1b,d were found to be the most potent, full 5-HT4 receptor agonists described so far (EC(50) = 0.5 and 0.8 nM, respectively), being 6 and 4 times more potent than serotonin itself. On the other hand, 5b and 1h appeared as partial 5-HT4 receptor agonists in the nonstimulated guinea pig ileum preparation with potencies, evaluated against serotonin action, respectively similar (5b, K-i = 12 nM) to and 300-fold higher (1h, K-i = 0.04 nM) than serotonin.
    DOI:
    10.1021/jm00013a010
  • 作为产物:
    描述:
    5-甲氧基靛红 在 sodium hydroxide 、 硫酸 、 sodium nitrite 、 盐酸 、 tin(II) chloride dihdyrate 作用下, 以 为溶剂, 生成 5-甲氧基-3-吲唑羧酸
    参考文献:
    名称:
    探索新型吲唑衍生物作为 ASK1 抑制剂:设计、合成、生物学评价和对接研究
    摘要:
    凋亡信号调节激酶 1 (ASK1、MAP3K5) 是丝裂原激活蛋白激酶 (MAPK) 信号通路的成员,参与细胞存活、分化、应激反应和凋亡。 ASK1 激酶抑制已成为治疗非酒精性脂肪性肝炎 (NASH) 疾病的一种有前途的策略。设计并合成了一系列具有吲唑支架的新型ASK1抑制剂,并评估了它们的ASK1激酶活性。系统结构活性关系(SAR)研究发现了一种有前途的化合物,它对ASK1有很强的抑制作用。值得注意的观察结果包括油红 O 染色的 LO2 细胞内脂滴明显减少,以及 NASH 模型细胞组内 LDL、CHO 和 TG 含量的减少。机制研究表明,该化合物可以抑制 TNF-α 处理的 HGC-27 细胞中上调的 ASK1-p38/JNK 信号通路的蛋白表达水平,并调节凋亡蛋白。总之,这些发现表明该化合物作为抗 NASH 的潜在候选化合物可能对进一步研究有价值。
    DOI:
    10.1016/j.bioorg.2024.107391
点击查看最新优质反应信息

文献信息

  • Thiazolylbenzofuran derivatives and pharmaceutical compositions
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US05994378A1
    公开(公告)日:1999-11-30
    This invention relates to novel thiazolylbenzofuran derivatives of formula (I) wherein R.sup.1 is lower alkyl, L is single bond or lower alkylene optionally substituted with aryl, oxo or hydroxy, and Q is a heterocyclic group optionally substituted with one or more suitable substituent(s); or lower alkoxy substituted with aryl which is substituted with one or more suitable substituent(s) and at least one of which is lower alkoxy optionally substituted with cyano, protected carboxy, carboxy, lower alkylene, a heterocyclic group optionally substituted with oxo, or amidino optionally substituted with hydroxy or lower alkoxy, or its salt, which possess activities as leukotriene and SRS-A antagonists or inhibitors.
    本发明涉及新颖的噻唑基苯并呋喃衍生物,其具有公式(I),其中R1是低级烷基,L是单键或可被芳基、氧基或羟基取代的低级亚烷基,Q是可被一个或多个适当取代基取代的杂环基;或者是被芳基取代的低级烷氧基,该芳基被一个或多个适当取代基取代,并且至少一个是可被氰基、受保护的羧基、羧基、低级亚烷基、可被氧基取代的杂环基或可被羟基或低级烷氧基取代的胍基取代的低级烷氧基,或其盐,其具有作为白三烯和SRS-A拮抗剂或抑制剂的作用。
  • Development of Potent Serotonin-3 (5-HT3) Receptor Antagonists. II. Structure-Activity Relationships of N-(1-Benzyl-4-methylhexahydro-lH-1,4-diazepin-6-yl)carboxamides.
    作者:Hiroshi HARADA、Toshiya MORIE、Yoshimi HIROKAWA、Hideo TERAUCHI、Iwao FUJIWARA、Naoyuki YOSHIDA、Shiro KATO
    DOI:10.1248/cpb.43.1912
    日期:——
    reflex in rats are described. Heteroaromatic rings such as pyrrole, thiophene, furan, pyridine, pyridazine, 1,2-benzisoxazole, indole, quinoline, and isoquinoline rings showed weak 5-HT3 receptor antagonistic activity. Within this series, use of the 1H-indazole ring as an aromatic moiety led to a substantial increase of the activity; the 1H-indazolylcarboxamides 54, 57, 97, and 102 showed potent 5-HT3
    我们对4-氨基-5-氯-2-乙氧基苯甲酰胺的研究导致发现N-(1,4-二甲基六氢-1H-1,4-二氮杂-6-6基)苯甲酰胺9和1-苄基-4 -甲基六氢-1H-1,4-二氮杂analogue类似物10是有效的血清素3(5-HT3)受体拮抗剂。描述了结构和活性关系(SAR)研究9和10的芳香核对大鼠von Bezold-Jarisch反射的抑制作用。杂芳族环,如吡咯,噻吩,呋喃,吡啶,哒嗪,1,2-苯并恶唑环,吲哚,喹啉和异喹啉环显示弱的5-HT3受体拮抗活性。在这个系列中,使用1H-吲唑环作为芳族部分会导致活性的大幅提高。1H-吲唑基羧酰胺54、57、97和102显示出有效的5-HT3受体拮抗活性。
  • [EN] NOVEL TETRAHYDROPYRIDOPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION<br/>[FR] NOUVELLES TÉTRAHYDROPYRIDOPYRIMIDINES POUR LE TRAITEMENT ET LA PROPHYLAXIE D'UNE INFECTION PAR LE VIRUS DE L'HÉPATITE B
    申请人:HOFFMANN LA ROCHE
    公开号:WO2018083106A1
    公开(公告)日:2018-05-11
    The present invention provides novel compounds having the general formula (I) wherein R1, R2 and Z are as described herein, compositions including the compounds and methods of using the compounds.
    本发明提供了具有一般式(I)的新化合物,其中R1、R2和Z如本文所述,包括这些化合物的组合物和使用这些化合物的方法。
  • [EN] ALKYNYL ALCOHOLS AND METHODS OF USE<br/>[FR] ALCOOLS D'ALCYNYLE ET PROCÉDÉS D'UTILISATION CORRESPONDANTS
    申请人:HOFFMANN LA ROCHE
    公开号:WO2015025025A1
    公开(公告)日:2015-02-26
    The invention relates to compounds of Formula (0): wherein Q, A1-A8, R4 and R5 and each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over- activation of NF-kB signaling is observed.
    这项发明涉及以下式的化合物(0):其中Q,A1-A8,R4和R5分别具有如本文所述的含义。式(0)的化合物及其药物组成物在治疗观察到NF-kB信号通路的不良或过度活化的疾病和紊乱中是有用的。
  • Design and synthesis of a new indazole library: direct conversion of N-methoxy-N-methylamides (Weinreb amides) to 3-keto and 3-formylindazoles
    作者:François Crestey、Silvia Stiebing、Rémi Legay、Valérie Collot、Sylvain Rault
    DOI:10.1016/j.tet.2006.10.063
    日期:2007.1
    Grignard or lithiated reagents on the new Weinreb amides 3 and 4 afforded efficiently the corresponding ketones and allowed the design and synthesis of a new indazole library. These 3-ketoindazoles were obtained by a direct and original conversion of N-methoxy-N-methylamides with good yields. Furthermore, the reduction of 3 with LiAlH4 furnished the corresponding aldehydes as a versatile and efficient pathway
    在新的Weinreb酰胺3和4上亲核添加格氏试剂或锂化试剂可有效提供相应的酮,并允许设计和合成新的吲唑文库。这些3-酮吲唑是通过N-甲氧基-N-甲基酰胺的直接和原始转化以良好的收率获得的。此外,用LiAlH 4还原3可以提供相应的醛,作为通向3-甲酰基吲唑的一种通用而有效的途径。
查看更多